OpenEvidence and Glass Health both support evidence-backed clinical questions, encounter documentation, and patient-context workflows. Choose OpenEvidence when publisher partnerships, Visits, and DeepConsult lead the evaluation. Choose Glass when the workflow requires structured differential diagnosis, problem-based assessment-and-plan drafting, and supported EHR integration in the same product.
OpenEvidence should no longer be treated as a question-only reference tool. Visits transcribes encounters, enriches the assessment and plan with evidence, supports custom note templates, organizes patient documents, and lets clinicians query patient history. The sharper comparison is between OpenEvidence’s evidence-and-content advantage and Glass’s structured encounter reasoning workflow.
The decision in brief
- Choose OpenEvidence when publisher-backed evidence retrieval, deep research, and free verified-clinician access are primary.
- Choose Glass when structured DDx and problem-based A&P, published capacity tiers, and supported EHR integration are primary.
- Both products now support encounter documentation and patient context; a note-only-versus-reference comparison is outdated.
- Verify the exact BAA, deployment terms, and EHR workflow for the account and organization that will use the product.
What OpenEvidence is built to do
OpenEvidence combines a clinical information assistant with licensed and partnered content from NEJM, JAMA, NCCN, Wiley, Cochrane, and other sources. That content access is its clearest differentiation.
Visits extends the product into the encounter. It provides evidence-backed transcription, custom templates, document collection, patient-record search, note editing, and literature search. Clinicians can use the resulting record as context for later questions.
DeepConsult supports deeper evidence synthesis for complex questions. OpenEvidence also states that it is HIPAA compliant and that U.S. covered entities entering PHI do so under its Business Associate Agreement (OpenEvidence HIPAA announcement). Confirm that the agreement applies to the exact account and workflow before entering PHI.
Glass Health vs OpenEvidence
| Topic | Glass Health | OpenEvidence |
|---|---|---|
| Primary product | Ambient scribing plus structured CDS | Medical information platform plus encounter tools |
| Evaluation path | Public signup and published pricing | Free access for verified U.S. clinicians |
| Visit workflow | Ambient scribing, live insights, structured DDx, A&P, and Q&A | Transcription, evidence-enriched notes, documents, and patient-context questions |
| Clinical support | Structured differential diagnosis, problem-based A&P, and clinical Q&A | Evidence-backed answers, DeepConsult, publisher content, and visit-aware questions |
| Evidence advantage | Citations in clinical Q&A and CDS outputs | Direct content partnerships with major medical publishers and organizations |
| EHR workflow | Epic, eClinicalWorks, athenahealth, and Elation on Max | Confirm the current integration path for the intended deployment |
| Pricing visibility | Public monthly plans | Free verified-clinician access rather than a monthly subscription ladder |
Where OpenEvidence leads the comparison
OpenEvidence is strongest when evidence retrieval is the center of the workflow. Its publisher partnerships, DeepConsult research mode, and free verified-clinician access create a compelling reference and synthesis product. Visits makes that evidence layer useful during and after the encounter rather than only in a separate search session.
Where Glass takes a different approach
Glass provides a more explicit structured reasoning workflow. Its ambient CDS produces differential diagnosis and problem-based assessment-and-plan outputs alongside documentation and clinical Q&A. Glass also publishes a capacity-based pricing ladder and supports Epic, eClinicalWorks, athenahealth, and Elation integration on Max.
How Does Pricing Compare Between Glass Health and OpenEvidence?
OpenEvidence access and pricing:
OpenEvidence emphasizes free access for verified U.S. healthcare professionals. Confirm institution-specific or enterprise arrangements directly with OpenEvidence.
| Plan | Monthly Price | Annual Price | Includes |
|---|---|---|---|
| Lite | Free ($0) | Free ($0) | Limited clinical decision support and ambient scribing |
| Starter | $20/month | $18/month | Standard ambient scribing and CDS, plus limited Deep Reasoning |
| Pro | $90/month | $81/month | Extended ambient scribing, CDS, and Deep Reasoning |
| Max | From $200/month | From $180/month | Maximum capacity, priority processing, and supported EHR integration |
The practical pricing contrast: both companies have a public way to start. OpenEvidence centers free access for verified clinicians. Glass Health lists a full plan ladder for buyers who want to benchmark individual or team deployment directly from the website.
When Should You Choose OpenEvidence Over Glass Health?
Choose OpenEvidence when:
- You want a point-of-care medical information platform built around clinical questions and evidence retrieval.
- Official content partnerships with major medical publishers and organizations matter in your review.
- You want to explore Visits and DeepConsult through the verified-clinician access model.
- Publisher-backed evidence search and synthesis are the primary differentiators.
When Should You Choose Glass Health Over OpenEvidence?
Choose Glass when:
- You want ambient scribing, structured differential diagnosis, assessment-and-plan drafting, and clinical Q&A in one accessible path.
- You want a published monthly pricing ladder for moving from individual use to broader deployment.
- You want the clinical encounter and the note workflow to be part of the same product evaluation.
- You use Epic, eClinicalWorks, athenahealth, or Elation and want a supported Max integration path.
Start with the Glass Health free tier today →
FAQ
Is OpenEvidence free?
OpenEvidence Visits is available without charge to verified U.S. healthcare professionals, and the DeepConsult announcement describes the same access model for verified U.S. clinicians.
What is OpenEvidence Visits?
Visits transcribes encounters, enriches the assessment and plan with evidence, supports custom note templates, organizes patient documents, and lets clinicians ask questions across patient history.
Is OpenEvidence HIPAA compliant?
OpenEvidence’s April 2025 announcement says the company is HIPAA compliant, that U.S. covered entities can securely input PHI, and that such usage is governed by OpenEvidence’s Business Associate Agreement.
What is DeepConsult?
OpenEvidence’s July 2025 announcement describes DeepConsult as an AI agent purpose-built for physicians and says it is free to verified U.S. clinicians.
Can I use OpenEvidence alongside Glass Health?
Yes. Some clinicians may want Glass for ambient documentation and Glass Health CDS while also evaluating OpenEvidence for question-driven evidence retrieval. The right choice depends on whether your starting use case is the clinical encounter workflow, the evidence-search workflow, or both.
Bottom line
OpenEvidence is the stronger starting point when publisher-backed evidence access and deep research define the purchase. Glass is the stronger starting point when structured DDx, problem-based A&P, published capacity tiers, and supported EHR integration define the workflow. Both now support documentation and patient context, so the decision should be based on the exact outputs and operating model rather than an outdated category label.
When the evaluation includes documentation, structured DDx, and A&P rather than evidence search alone, try the Glass workflow or review the OpenEvidence alternatives guide.